An Observational Study on The Prediction of Adverse Events in Patients With Chronic Hepatitis C Receiving a Long-Acting Interferon Plus Ribavirin (GUARD-C)
Clinical trial NCT01344889 · COMPLETED
Trial details
- NCT number
- NCT01344889
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2009-10-01
- Primary completion
- 2013-06-01
- Enrollment
- 4459
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.